Article Text

Download PDFPDF
Global hepatitis, migration and its impact on Western healthcare

Statistics from Altmetric.com

Footnotes

  • Competing interests Dr Furqaan Ahmed has none to declare. Professor Foster has received funding from companies that manufacture drugs used to treat viral hepatitis. Specifically he has received consultancy fees from Roche, Novartis, Chughai, Tibotec, Gilead and BMS and he has received grant funding from Roche, Chughai and Gilead.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.